Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 5 (2008), Issue 10 (October)

1. Complementing mutations in core binding factor leukemias: from mouse models to clinical applications.
   Oncogene, 27(44): 5759-73. [Abstract] [Full-text]
2. Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit.
   J Biol Chem, 283(41): 27444-51. [Abstract] [Full-text]
3. Assessment of Aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis.
   Clin Vaccine Immunol, 15(10): 1625-8. [Abstract] [Full-text]
4. Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.
   Blood, 112(8): 3484-7. [Abstract] [Full-text]
5. Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
   Blood, 112(8): 3130-4. [Abstract] [Full-text]
6. Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia.
   Blood, 112(8): 3391-402. [Abstract] [Full-text]
7. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
   Blood, 112(8): 3383-90. [Abstract] [Full-text]
8. Clofarabine combinations as acute myeloid leukemia salvage therapy.
   Cancer, 113(8): 2090-6. [Abstract] [Full-text]
9. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
   J Clin Oncol, 26(29): 4791-7. [Abstract] [Full-text]
10. Array-based comparative genomic hybridization characterizes a deletion associated with a t(15;17) in acute promyelocytic leukemia.
    Am J Clin Pathol, 130(5): 818-23. [Abstract] [Full-text]
11. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
    Leukemia, 22(10): 1899-908. [Abstract] [Full-text]
12. Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.
    Pediatr Blood Cancer, 51(6): 784-6. [Abstract] [Full-text]
13. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
    Pediatr Blood Cancer, 51(6): 741-6. [Abstract] [Full-text]
14. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    J Clin Oncol, 26(30): 4944-51. [Abstract] [Full-text]
15. Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
    J Clin Oncol, 26(30): 4934-9. [Abstract] [Full-text]
16. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.
    Cancer Genet Cytogenet, 186(2): 115-9. [Abstract] [Full-text]
17. Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.
    Blood, 112(9): 3587-90. [Abstract] [Full-text]
18. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.
    Blood, 112(9): 3574-81. [Abstract] [Full-text]
19. Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival.
    Ann Oncol, 19(11): 1927-34. [Abstract] [Full-text]
20. Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
    Oncology, 75(3): 203-14. [Abstract] [Full-text]
21. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
    J Clin Oncol, 26(31): 5078-87. [Abstract] [Full-text]
22. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    J Clin Oncol, 26(31): 5088-93. [Abstract] [Full-text]

© 2004-2010 Acute Myeloid Leukemia Research Today. All Rights Reserved.